Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.9.4645

Metaplastic Breast Carcinoma: Case Series and Review of the Literature  

Esbah, Onur (Department of Medical Oncology, Ankara Oncology Teaching and Research Hospital)
Turkoz, Fatma P. (Department of Medical Oncology, Ankara Oncology Teaching and Research Hospital)
Turker, Ibrahim (Department of Medical Oncology, Trabzon Research and Training Hospital)
Durnali, Ayse (Department of Medical Oncology, Ankara Oncology Teaching and Research Hospital)
Ekinci, Ahmet S. (Department of Medical Oncology, Ankara Oncology Teaching and Research Hospital)
Bal, Oznur (Department of Medical Oncology, Ankara Oncology Teaching and Research Hospital)
Sonmez, Ozlem Uysal (Department of Medical Oncology, Sakarya Research and Training Hospital)
Budakoglu, Burcin (Department of Medical Oncology, Ankara Oncology Teaching and Research Hospital)
Arslan, Ulku Y. (Department of Medical Oncology, Ankara Oncology Teaching and Research Hospital)
Oksuzoglu, Berna (Department of Medical Oncology, Ankara Oncology Teaching and Research Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.9, 2012 , pp. 4645-4649 More about this Journal
Abstract
Metaplastic breast carcinoma (MpBC) is a rare disease entity, accounting for less than 1% of all breast carcinomas. Furthermore, it is a heterogenous disease with different subgroups, including malignant epithelial (carcinoma) and stromal (sarcoma) features. Here we evaluated, retrospectively, 14 female MpBC patients admitted to Ankara Oncology Training and Research Hospital between 2005 and 2011. Median age was 45.5 (range:16.0-76.0) and tumor size 57.5 mm (range: 20.0-80.0 mm). Histopathological subtypes were as follows: 5 carcinosarcoma, 5 squamous and 4 adenosquamous carcinoma. All but one with upfront lung metastasis, had their primary breast tumor operated. Axillary lymph nodes were involved in 64.3%. The most common sites of metastasis were lungs and brain. Chemotherapy including antracycline, taxane and even platinium was planned for adjuvant, neoadjuvant and palliative purposes in 9, 3 and 1 patient, respectively. Median cycles of chemotherapy was 6 (range:4-8). Median follow-up of the patients was 52 months (95%CI 10.4-93.6 month). Median 3 year progression free survival (PFS) and overall survival (OS) in this patients cohort were 33% and 56%, respectively. In conclusion, MpBC is a rare and orphan disease without standardized treatment approaches and the prognosis is poor so that larger studies to investigate different treatment schedules are urgently needed.
Keywords
Breast metaplastic carcinoma; rare disease; orphan status; poor prognosis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lim KH,Oh DY,Chie EK, et al (2010). Metaplastic breast carcinoma: clinicopathologic features and prognostic value of triple negativity. Jpn J Clin Oncol, 40, 112-8.   DOI
2 Luini A, Aguilar M, Gatti G, et al (2007). Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat, 101, 349-53.   DOI   ScienceOn
3 Mouder S, Moroney J, helgason T (2011). Responses liposomal doxorubicin,bevacuzimab and temsirolimus in metaplastic carcinoma of the breast:biologic rationale and implications for stem -cell research in breast cancer. J Clinical Oncol, 29, 572-5.   DOI
4 Oberman HA (1987). Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients. Am J Surg Pathol, 11, 918-29.   DOI   ScienceOn
5 Park JH, Han W, Kim SW et al (2005). The clinicopathologic characteristics of 38 metaplastic carcinomas of the breast. J Breast Cancer, 8, 59-63.   DOI
6 Park HS, Park S, Kim JH, et al (2010). Clinicopathologic features and outcomes of metaplastic breast carcinoma: comparison with invasive ductal carcinoma of the breast. Yonsei Med J, 51, 864-9.   DOI
7 Pitts WC, Rojas VA, Gaffey MJ, et al (1991). Carcinomas with metaplasia and sarcomas of the breast. Am J Clin Pathol, 95, 623-32.
8 Rayson D, Adjei AA, Suman VJ, et al (1999). Metaplastic breast cancer: prognosis and response to systemic therapy. Ann Oncol, 10, 413-9.   DOI   ScienceOn
9 Reis-Filho JS, Milanezi F, Steele D, et al (2006). Metaplastic breast carcinomas are basal-like tumours. Histopathology, 49, 10-21.   DOI
10 Al Sayed AD, El Weshi AN, Tulbah AM, et al (2006). Metaplastic carcinoma of the breast clinical presentation, treatment results and prognostic factors. Acta Oncol, 45, 188-95.   DOI   ScienceOn
11 Bae SY, Lee SK, Koo MY, et al (2011). The prognoses of metaplastic breast cancer patients compared to those triple negative breast cancer patients. Breast Cancer Res and Treatment, 126, 471-28.   DOI
12 Bauer TW, Rostock RA, Eggleston JC, et al (1984). Spindle cell carcinoma of the breast: four cases and review of the literature. Hum Pathol, 15, 147-52.   DOI
13 Beatty JD, Atwood M, Tickman R, et al (2006). Metaplastic breast cancer: clinical significance. Am J Surg, 191, 657-64.   DOI
14 Caceres M, Shih J, Eckert M, et al (2002). Metaplastic carcinoma in an ectopic breast. South Med J, 95, 462-6.   DOI
15 Carlson RW, Allred DC, Anderson BO, et al (2009). NCCN breast cancer clinical practice guidelines panel. breast cancer. clinical practice guidelines in oncology. J Natl Compr Canc Netw, 7, 122-92.
16 Chao TC, Wang CS, Chen SC, et al (1999). Metaplastic carcinomas of the breast. J Surg Oncol, 71, 220-5.   DOI   ScienceOn
17 Chien T, Chou J, Chang T, et al (2010). Successful treatment of biphasic metaplastic sarcomatoid carcinoma of the breast by evaluation of immunohistochemical markers. Hematol Oncol Stem Cell Ther, 3, 89-93.   DOI
18 Sarah DR, Tseng WH, Martinez SR (2012). Treatment options for metaplastic breast cancer,international scholarly research network ISRN. Oncology, 2012, 706162.
19 Son BH, Ahn SH (2006). Survival analysis of korean breast cancer patients diagnosed between 1993 and 2002 in korea- a nation- wide study of the cancer registry. J Breast Cancer, 9, 214-29.   DOI
20 Tavassoli FA (1992). Classification of metaplastic carcinomas of the breast. Pathol Annu, 27, 89-119.
21 Toumi Z, Bullen C, Tang AC, et al (2011). Metaplastic breast carcinoma: a case report and systematic review of the literature. Pathol Int, 61, 582-8.   DOI   ScienceOn
22 Tseng WH, Martinez SR (2011). Metaplastic breast cancer:to radiate or not to radiate? Ann Surg Oncol, 18, 94-103,   DOI
23 Wargotz ES, Deos PH, Norris HJ (1989). Metaplastic carcinomas of the breast. II. Spindle cell carcinoma. Hum Pathol, 20, 732-40.   DOI   ScienceOn
24 Wargotz ES, Norris HJ (1989). Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. Hum Pathol, 20, 628-35.   DOI   ScienceOn
25 Wargotz ES, Norris HJ (1990). Metaplastic carcinomas of the breast: V. Metaplastic carcinoma with osteoclastic giant cells. Hum Pathol, 21, 1142-50.   DOI
26 Wargotz ES, Norris HJ (1989). Metaplastic carcinomas of the breast. III. Carcinosarcoma. Cancer, 64, 1490-9.   DOI
27 Wargotz ES, Norris HJ (1990). Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal origin. Cancer, 65, 272-6.   DOI   ScienceOn
28 Glaberman UB, Graham A, Stopeck A (2010). A case of metaplastic carcinoma of breast responsive to chemotherapy with ifosfamide and etoposide :improved antitumor responce by targeting sarcomatous features. Breast J, 16, 663-5.   DOI
29 Gersell DJ, Katzenstein AL (1981). Spindle cell carcinoma of the breast. A clinocopathologic and ultrastructural study. Hum Pathol, 12, 550-61.   DOI
30 Gutman H, Pollock RE, Janjan NA, et al (1995). Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast. J Am Coll Surg, 180, 193-9.
31 Huvos AG, Lucas JC Jr, Foote FW Jr (1973). Metaplastic breast carcinoma. Rare form of mammary cancer. NY State J Med, 73, 1078-82.
32 Kaufman MW, Marti JR, Gallager HS, et al (1984). Carcinoma of the breast with pseudosarcomatous metaplasia. Cancer, 53, 1908-17.   DOI   ScienceOn
33 Khan HN, Wyld L, Dunne B, et al (2003). Spindle cell carcinoma of the breast: a case series of a rare histological subtype. Eur J Surg Oncol, 29, 600-3.   DOI
34 Kim EY, Lee S, Bae TS, et al (2007). The clinical characteristics and predictive factors of stage IV breast cancer at the initial presentation: a review of a single institute's data. J Breast Cancer, 10, 101-6.   DOI
35 Korsching E, Jeffrey SS, Meinerz W, et al (2008). Basal carcinoma of the breast revisited: an old entity with new interpretations. J Clin Pathol, 61, 553-60.   DOI
36 Kuo SH, Chen CL, Huang CS, et al (2000). Metaplastic carcinoma of the breast: analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer. Anticancer Res, 20, 2219-22.